Jane Street Group LLC reduced its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 52.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,273 shares of the company's stock after selling 9,018 shares during the period. Jane Street Group LLC's holdings in Addus HomeCare were worth $1,101,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently modified their holdings of ADUS. Quarry LP acquired a new position in shares of Addus HomeCare during the 3rd quarter worth about $28,000. Quest Partners LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $31,000. Farther Finance Advisors LLC raised its stake in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after purchasing an additional 366 shares in the last quarter. Sandia Investment Management LP bought a new stake in Addus HomeCare during the second quarter worth $58,000. Finally, GAMMA Investing LLC lifted its stake in Addus HomeCare by 25.7% in the third quarter. GAMMA Investing LLC now owns 935 shares of the company's stock valued at $124,000 after acquiring an additional 191 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.
Addus HomeCare Stock Performance
Shares of Addus HomeCare stock traded down $0.93 on Tuesday, reaching $125.35. 89,089 shares of the stock were exchanged, compared to its average volume of 133,451. The firm's 50 day moving average is $125.46 and its 200-day moving average is $125.65. The firm has a market cap of $2.27 billion, a PE ratio of 28.68, a P/E/G ratio of 2.11 and a beta of 1.02. Addus HomeCare Co. has a one year low of $85.94 and a one year high of $136.12.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $289.80 million during the quarter, compared to analysts' expectations of $289.42 million. During the same quarter in the previous year, the firm earned $1.03 EPS. Addus HomeCare's revenue was up 7.1% on a year-over-year basis. On average, equities research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.
Insider Buying and Selling
In related news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the company's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares of the company's stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the stock. Stephens upped their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a report on Wednesday, November 6th. Royal Bank of Canada restated an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. JMP Securities began coverage on Addus HomeCare in a report on Monday, December 16th. They set an "outperform" rating and a $150.00 price target for the company. Finally, KeyCorp initiated coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of "Buy" and an average price target of $133.67.
Read Our Latest Report on ADUS
Addus HomeCare Company Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.